ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 939

$779K Total Retail Price of All Prescriptions

Rank: 95 out of 939

398 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

36% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 13,082 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 972 515 S3 1 1
FUROSEMIDE 803 580 2 7
POTASSIUM CHLORIDE 688 540 3 9
AMLODIPINE BESYLATE 603 447 4 6
SIMVASTATIN 561 452 5 2
LISINOPRIL 440 282 6 3
METFORMIN HCL 400 251 7 8
MELOXICAM 393 218 8 14
OMEPRAZOLE 392 295 9 5
LEVOTHYROXINE SODIUM 337 278 10 4
METOPROLOL TARTRATE 323 243 11 10
TAMSULOSIN HCL 310 282 12 27
CITALOPRAM HBR 301 216 13 15
AZITHROMYCIN 269 192 14 32
FAMOTIDINE 262 184 15 62
ATORVASTATIN CALCIUM 225 165 16 22
WARFARIN SODIUM 219 119 17 17
NAMENDA 206 186 18 49
GABAPENTIN 200 119 19 11
NEXIUM 196 111 20 18
DONEPEZIL HCL 192 173 21 30
RISPERIDONE 179 127 22 82
CLONIDINE HCL 178 116 23 39
ZOLPIDEM TARTRATE 176 110 24 20
CIPROFLOXACIN HCL 175 90 25 54
TRAMADOL HCL 174 93 26 16
SUCRALFATE 171 136 27 96
HYDROCHLOROTHIAZIDE 164 115 28 12
GLIPIZIDE 152 110 29 52
ALLOPURINOL 148 127 30 31
DIVALPROEX SODIUM 142 63 31 95
SERTRALINE HCL 134 104 32 24
CARVEDILOL 131 88 33 25
METOPROLOL SUCCINATE 130 96 34 21
CEPHALEXIN 122 47 35 77
POLYETHYLENE GLYCOL 3350 121 103 36 57
ATENOLOL 121 99 36 19
ISOSORBIDE MONONITRATE ER 116 99 38 53
PROAIR HFA 114 44 39 41
METHOCARBAMOL 114 48 R 39 149
INSULIN SYRINGE 112 51 41 97
FLUTICASONE PROPIONATE 112 83 41 43
HUMULIN N 109 73 43 253
NIFEDIPINE ER 95 95 44 105
ESCITALOPRAM OXALATE 94 83 45 61
ACETAMINOPHEN-CODEINE 94 81 S3 45 116
AMLODIPINE BESYLATE-BENAZEPRIL 93 92 47 58
CLOPIDOGREL 92 86 48 28
LEVOFLOXACIN 92 72 48 86
NYSTATIN 91 67 50 174
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 58 50 23
FINASTERIDE 90 90 52 131
PRAVASTATIN SODIUM 87 56 53 13
HYDRALAZINE HCL 86 73 54 130
DIGOXIN 85 68 55 45
MIRTAZAPINE 85 85 55 56
QUETIAPINE FUMARATE 79 69 57 69
DIOVAN 79 58 57 50
BUSPIRONE HCL 76 62 59 123
SYNTHROID 74 50 60 75
CEFDINIR 71 43 61 142
CYCLOBENZAPRINE HCL 70 0 R 62 36
AMIODARONE HCL 70 55 62 160
AGGRENOX 69 45 64 153
LOSARTAN POTASSIUM 67 54 65 29
PHENYTOIN SODIUM EXTENDED 66 23 66 99
DETROL LA 65 42 67 155
KETOCONAZOLE 65 28 67 229
BENAZEPRIL HCL 65 26 67 87
CRESTOR 64 55 70 34
LAMOTRIGINE 63 63 71 187
BENZTROPINE MESYLATE 63 26 R 71 175
PLAVIX 61 49 73 48
LYRICA 61 50 73 63
ALENDRONATE SODIUM 61 51 73 40
SPIRONOLACTONE 61 46 73 71
MEGESTROL ACETATE 59 59 R 77 136
GLIMEPIRIDE 59 37 77 37
MECLIZINE HCL 58 54 79 134
PAROXETINE HCL 56 37 80 70
FLUCONAZOLE 54 32 81 140
CEFTRIAXONE 52 36 82 197
CYMBALTA 51 35 83 44
RANITIDINE HCL 51 39 83 35
IPRATROPIUM BROMIDE 51 39 83 276
MUPIROCIN 50 32 86 185
TRIAMTERENE-HCTZ 50 46 86 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.